Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Oct 19.
Published in final edited form as: Angew Chem Int Ed Engl. 2009;48(37):6832–6835. doi: 10.1002/anie.200902501

Dilution-Free Analysis from Picoliter Droplets by Nano-ESI MS**

Ryan T Kelly 1,, Jason S Page 1, Ioan Marginean 1, Keqi Tang 1, Richard D Smith 1
PMCID: PMC2957286  NIHMSID: NIHMS143489  PMID: 19688798

The amount of sample required for a chemical analysis is frequently determined not by instrument sensitivity but by the ability to isolate, prepare and deliver trace analytes to the instrument. For example, in the case of proteomics, ∼50 proteins can be identified[1,2] from single-cell-sized (50 pg) tryptic digest samples that are prepared in bulk, diluted, and analyzed by ultrasensitive liquid chromatography/mass spectrometry (LC/MS). However, due to losses occurring during conventional sample preparation and challenges in working with small volumes on the benchtop, at least four orders of magnitude more starting material are still needed.[3] Microfluidic devices, with their flexible design, precise flow control, and ability to integrate multiple sample handling and analysis steps[4] offer promise for bridging this gap. A particularly attractive microfluidic approach for sample-limited analyses employs aqueous droplets or plugs encapsulated by an immiscible oil.[5-7] Each droplet serves as a discrete compartment or reaction chamber enabling, e.g., high throughput screening[8-9] and kinetic studies[10-12] of femto- to nanoliter samples, as well as the encapsulation[13-15] and lysis[13] of individual cells with limited dilution of the cellular contents.

A potential challenge for droplet-based platforms, however, is that detection is largely limited to a small number of resolvable species using, e.g., fluorescence; both chemical separations and more comprehensive detection methods such as mass spectrometry (MS) are incompatible with encapsulated droplets. As such, there is tremendous interest[7,16] in combining the unique characteristics of digital[17] and droplet-based microfluidics with continuous-flow microchannels, which can be accomplished by extracting the droplet contents into an aqueous stream for further processing and analysis. In the case of sample-limited analyses, the entire droplet should ideally be transferred to the aqueous channel with minimal analyte dilution. Transferring droplets from oil to aqueous streams while, e.g., keeping the carrier liquids separate has proven difficult.[18] Previous efforts have utilized spatially selective surface coating[18,19] to establish a boundary between the hydrophobic and aqueous phases or synchronized electrical pulses from embedded electrodes to drive the droplets from the oil to an aqueous stream.[20] The latter approach was recently used to analyze droplet contents by electrospray ionization (ESI) MS.[21] The aqueous channel into which the droplets were extracted operated in excess of 4 μL/min and the contents were flowed from the chip through tubing to a conventional, external sheath flow electrospray source. The large distance to the ESI emitter led to dilution of the droplet contents, and the high flow rates reduced ionization efficiencies,[22] resulting in limited sensitivity (∼500 μM detection limits for peptides).

We have been developing[23] devices capable of automatically transferring the contents of droplets to an aqueous stream for analysis by nano-ESI MS using integrated electrospray emitters, making much higher sensitivity analyses possible. The device overview is shown in Fig. 1. Aqueous 600–800 pL droplets (plugs) are generated on-chip and carried downstream by immiscible oil (Fig. 2A and Movie S1 in Supplementary Information). The geometry of the droplet generator enables sub-nanoliter droplets to be produced at low frequencies (∼0.1 Hz). The oil stream is separated from an adjacent aqueous stream by an array of cylindrical posts, forming 3-μm-wide apertures in between. Interfacial tension between the two immiscible liquids prevents bulk transfer for similar pressures in the two channels. However, the aqueous plugs rapidly coalesce with the aqueous stream upon contact through the apertures (Figure 2B and Movie S2 in Supplementary Information). While transfer typically occurs through only one or two apertures, the larger number of openings serves to buffer pressure imbalances between the channels and prevents bulk crossover of the oil and aqueous streams. Indeed, we were unable to form a stable oil-aqueous interface with a device having a single 3-μm-wide aperture. The rate of droplet transfer to the aqueous stream closely matched the flow rate of the oil channel (∼200 nL/min), which in this case was more than twice the flow rate of the carrier channel (80 nL/min). This rapid transfer resulted in a brief pressure spike in the aqueous carrier channel and minimized dilution due to mixing with the carrier solution. In fact, as shown by the MS data below, a large portion of each droplet transferred without mixing with the carrier solution at all, enabling essentially dilution-free analysis from the droplets.

Figure 1.

Figure 1

Device design. (A) Schematic of the device. Oil and the encapsulated aqueous solution were supplied through Ports (1) and (2), respectively. The aqueous carrier solution into which droplets were transferred was infused through Port (3). High voltage (∼+3 kV) to drive the electrospray was supplied at the stainless steel needle of the syringe providing carrier solution to Port (3). Port (4) was designed to supply electrically conductive solution through a channel for an in-Taylor-cone liquid junction[24] to enable electrophoretic separations and was not used for these experiments. Port (5) is the waste reservoir for the oil. The angled lines that are not connected to the fluidic circuitry served as guides for accurate cutting of the PDMS devices to form nano-ESI emitters, enabling variable distances from the droplet transfer region to the emitter to be easily obtained. (B) Droplet generator. (C) Droplet transfer region. The interface between the aqueous and oil channels was comprised of 6 cylindrical columns designed to be 15 μm in diameter each, leaving 3-μm-wide apertures in between. Channel widths are 50 μm for the droplet/oil channel and 20 μm for the aqueous stream leading to the ESI emitter. The channel above the aqueous stream in (C) was connected to Port (4) and was not used for this work.

Figure 2.

Figure 2

Micrograph sequences depicting device operation. (A) Droplet generation. Flow rates were 10 nL/min for the aqueous solution (blue) and 200 nL/min for the oil (clear) and matched those used to collect experimental data reported here. (B) Droplet transfer. The flow rate in the aqueous channel was 80 nL/min and also matched experimental conditions. The blurred appearance of the aqueous plug prior to transfer is due to the long exposure time of the imaging device.

The aqueous channel terminated at an integrated nano-ESI emitter, described previously,[24] created by making two vertical cuts through the polydimethylsiloxane (PDMS) device with the channel terminating at the apex. Because the nano-ESI source was integrated with the device and operated stably at 80 nL/min, it was possible to achieve much higher MS sensitivity from droplets than previously reported.[21] In the present design, the distance from the droplet transfer region to the ESI emitter, d, can be as short as 1 mm or as long as 3 cm depending on where the cuts defining the emitter are made; the longer distances are intended for CE separations. In this work we evaluated the effect of d on ESI-MS performance for direct infusion in terms of droplet peak widths and MS signal intensities as d was varied from 1 mm to 6 mm. Extracted ion traces for leu enkephalin are shown in Figs. 3A and 3B for d = 6 mm and 1 mm, respectively. A plot of peak width vs. d, which also provides approximate post-transfer residence times for different distances, is shown in Fig. 3S (Supplementary Information), and shows the considerable peak broadening that can occur over a distance of just 5 mm due to Taylor dispersion and diffusion.

Figure 3.

Figure 3

MS Data. (A–B) Extracted ion traces for leu enkephalin (m/z 556–557) obtained for d = 6 mm (A) and 1 mm (B). (C–D) Mass spectra obtained at the apexes of the peaks indicated by the dashed lines in (A) and (B), respectively. The red arrow in the expanded window in (D), pointing to m/z 574.2, highlights the absence of met enkephalin from the carrier solution stream.

The extent to which the droplet contents were diluted by the aqueous carrier solvent is examined in Figs. 3 (C–D) and 4. At a post-transfer distance of 6 mm (Fig. 3C), met enkephalin, spiked into the carrier solvent, is prominently observed at a peak apex in the leu enkephalin extracted ion trace resulting from a transfer event, indicating the extent of dilution. Also, the normalized peak intensity of leu enkephalin, obtained by comparing the ratio of its absolute intensity to that of met enkephalin in between transfer events with their in-solution intensity ratio, further verifies the dilution. Fig. 3D shows a similar spectrum for d = 1 mm. In this case, the normalized intensity is unity, and the met enkephalin signal intensity decreases by 99.7% to chemical background levels, such that the maximum extent of dilution by the carrier solvent is ∼0.3%. Fig. 4S (Supplementary Information) shows that the leu enkephalin peak disappears completely in between transfer events, indicating that cross-contamination of droplet contents is not an issue. As Figs. 3C and 3D show MS data only at the apex of the transferred peaks, Fig. 4 provides a profile for both leu enkephalin and met enkephalin defining a complete transfer event for d = 1 mm, and shows that a droplet can provide multiple spectra unaffected by dilution.

Figure 4.

Figure 4

Plot of MS intensities of leu enkephalin (originating from the droplet) and met enkephalin (originating from the carrier solution) along the profile of a transferred droplet peak. The distance from the droplet transfer region to the emitter was 1 mm.

The described device combines droplet-based microfluidics with continuous flow microsystems in a manner that enables high-sensitivity nano-ESI MS detection, with the present work representing a ∼3-order-of-magnitude gain in sensitivity over previous work.[21] The simple method described for droplet transfer and the efficient coupling of droplet technology with MS detection have numerous potential applications. For example, the rapid transfer times (∼200 ms) should enable a new method for monitoring diffusion coefficients by MS[25] and are sufficiently fast to serve as injection events for rapid, high resolution microchip capillary electrophoresis (μ-CE) separations. Such an injection mechanism for μ-CE should provide a significant advantage for sample-limited analyses over conventional cross injectors,[26] which send the majority of the sample to waste. Droplet-mediated multidimensional separations become feasible with this injection mechanism as well, provided that the transferred droplets comprise the compartmentalized eluent[27] from an orthogonal separation (e.g., LC). Finally, by using the droplets to encapsulate and prepare individual cells in a lossless fashion, and coupling the platform with new technologies designed to maximize ionization and transmission efficiencies such as low-pressure nano-ESI MS[28] for optimum sensitivity, this platform could open the door to single-cell, MS-based proteomics.

Experimental Section

Leucine enkephalin (YGGFL) and methionine enkephalin (YGGFM) were purchased as solids from Sigma-Aldrich (St. Louis, MO, USA), diluted to 100 μM in water, and further diluted to their final concentrations of 1 μM each in the carrier solvent; the ESI-compatible carrier solvent consisted of 9:1 water:methanol + 0.1% acetic acid. The oil used was perfluorodecalin (Sigma). Devices were fabricated in PDMS using conventional soft lithography from a single photomask followed by irreversible bonding to a PDMS cover plate by treatment with a corona source as described previously;[24] channel depths were ∼20 μm. Following bonding, devices were heated to 120 °C overnight to recover the hydrophobicity of the surface.[18] Liquids were infused from 50 μL syringes (Hamilton, Reno, NV, USA) controlled by Harvard PHD 2000 syringe pumps (Holliston, MA, USA), Through-holes and the fluidic connections between the fused silica capillaries and the microdevices were made as described previously. MS measurements were made using an ion funnel-modified[23] orthogonal time-of-flight instrument (Agilent Technologies, Santa Clara, CA, USA) set to record spectra at 5 Hz. The in-solution intensity ratio of the two peptides was determined by direct infusion ESI MS of an equimolar mixture using a 20-μm-i.d. chemically etched[29] fused silica emitter operated at 100 nL/min.

Supplementary Material

Figure S3. Plot of peak width vs. d (upper abscissa) and approximate post-transfer residence time (lower abscissa).

Figure S4. Mass spectrum obtained 1.2 s after that in Fig. 3D. The red arrow in the expanded window points to the monoisotopic mass position of leu enkephalin; its absence indicates that there is no observable carryover between droplets.

Footnotes

**

This research was supported by the U.S. D.O.E. Office of Biological and Environmental Research, the NIH NCRR (RR018522), the National Institute of Allergy and Infectious Diseases and the WA State Life Sciences Discovery Fund. Microfabrication and experimental work were performed in the PNNL Environmental Molecular Sciences Laboratory.

References

  • 1.Shen Y, Tolić N, Masselon C, Paša-Tolić L, Camp DG, Hixson KK, Zhao R, Anderson GA, Smith RD. Anal Chem. 2004;76:144. doi: 10.1021/ac030096q. [DOI] [PubMed] [Google Scholar]
  • 2.Shen Y, Tolić N, Masselon C, Paša-Tolić L, Camp DG, Lipton MS, Anderson GA, Smith RD. Anal Bioanal Chem. 2004;378:1037. doi: 10.1007/s00216-003-2329-8. [DOI] [PubMed] [Google Scholar]
  • 3.Wang HX, Qian WJ, Mottaz HM, Clauss TRW, Anderson DJ, Moore RJ, Camp DG, Khan AH, Sforza DM, Pallavicini M, Smith DJ. J Proteome Res. 2005;4:2397. doi: 10.1021/pr050160f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kelly RT, Woolley AT. Anal Chem. 2005;77:96A. doi: 10.1021/ac0501083. [DOI] [PubMed] [Google Scholar]
  • 5.Teh SY, Lin R, Hung LH, Lee AP. Lab Chip. 2008;8:198. doi: 10.1039/b715524g. [DOI] [PubMed] [Google Scholar]
  • 6.Huebner A, Sharma S, Srisa-Art M, Hollfelder F, Edel JB, deMello AJ. Lab Chip. 2008;8:1244. doi: 10.1039/b806405a. [DOI] [PubMed] [Google Scholar]
  • 7.Chiu DT, Lorens RM, Jeffries GDM. Anal Chem. 2009;81 doi: 10.1021/ac900306q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Clausell-Tormos J, Lieber D, Baret JC, El-Harrak A, Miller OJ, Frenz L, Blouwolff J, Humphry KJ, Koster S, Duan H, Holtze C, Weitz DA, Griffiths AD, Merten CA. Chem Biol. 2008;15:427. doi: 10.1016/j.chembiol.2008.04.004. [DOI] [PubMed] [Google Scholar]
  • 9.Joensson HN, Samuels ML, Brouzes ER, Medkova M, Uhlen M, Link DR, Andersson-Svahn H. Angew Chem Int Ed. 2009;48:2518. doi: 10.1002/anie.200804326. [DOI] [PubMed] [Google Scholar]
  • 10.Srisa-Art M, Dyson EC, Demello AJ, Edel JB. Anal Chem. 2008;80:7063. doi: 10.1021/ac801199k. [DOI] [PubMed] [Google Scholar]
  • 11.Beer NR, Rose KA, Kennedy IM. Lab Chip. 2009;9:841. doi: 10.1039/b818478j. [DOI] [PubMed] [Google Scholar]
  • 12.Laval P, Crombez A, Salmon JB. Langmuir. 2009;25:1836. doi: 10.1021/la802695r. [DOI] [PubMed] [Google Scholar]
  • 13.He MY, Edgar JS, Jeffries GDM, Lorenz RM, Shelby JP, Chiu DT. Anal Chem. 2005;77:1539. doi: 10.1021/ac0480850. [DOI] [PubMed] [Google Scholar]
  • 14.Koster S, Angile FE, Duan H, Agresti JJ, Wintner A, Schmitz C, Rowat AC, Merten CA, Pisignano D, Griffiths AD, Weitz DA. Lab Chip. 2008;8:1110. doi: 10.1039/b802941e. [DOI] [PubMed] [Google Scholar]
  • 15.Edd JF, Di Carlo D, Humphry KJ, Koster S, Irimia D, Weitz DA, Toner M. Lab Chip. 2008;8:1262. doi: 10.1039/b805456h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Belder D. Angew Chem Int Ed. 2009;48:3736. doi: 10.1002/anie.200900184. [DOI] [PubMed] [Google Scholar]
  • 17.Abdelgawad M, Watson MWL, Wheeler AR. Lab Chip. 2009;9:1046. doi: 10.1039/b820682a. [DOI] [PubMed] [Google Scholar]
  • 18.Edgar JS, Pabbati CP, Lorenz RM, He MY, Fiorini GS, Chiu DT. Anal Chem. 2006;78:6948. doi: 10.1021/ac0613131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Roman GT, Wang M, Shultz KN, Jennings C, Kennedy RT. Anal Chem. 2008;80:8231. doi: 10.1021/ac801317t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fidalgo LM, Whyte G, Bratton D, Kaminski CF, Abell C, Huck WTS. Angew Chem Int Ed. 2008;47:2042. doi: 10.1002/anie.200704903. [DOI] [PubMed] [Google Scholar]
  • 21.Fidalgo LM, Whyte G, Ruotolo BT, Benesch JLP, Stengel F, Abell C, Robinson CV, Huck WTS. Angew Chem Int Ed. 2009;48:3665. doi: 10.1002/anie.200806103. [DOI] [PubMed] [Google Scholar]
  • 22.Wilm M, Mann M. Anal Chem. 1996;68:1. doi: 10.1021/ac9509519. [DOI] [PubMed] [Google Scholar]
  • 23.Kelly RT, Page JS, Tang K, Smith RD. U S Pat Appl 12/430,490. 2009 April 27;
  • 24.Kelly RT, Tang K, Irimia D, Toner M, Smith RD. Anal Chem. 2008;80:3824. doi: 10.1021/ac8000786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Clark SM, Leaist DG, Konermann L. Rapid Commun Mass Spectrom. 2002;16:1454. doi: 10.1002/rcm.732. [DOI] [PubMed] [Google Scholar]
  • 26.Jacobson SC, Hergenroder R, Koutny LB, Warmack RJ, Ramsey JM. Anal Chem. 1994;66:1107. [Google Scholar]
  • 27.Edgar JS, Milne G, Zhao Y, Pabbati CP, Lim DSW, Chiu DT. Angew Chem Int Ed. 2009;48:2719. doi: 10.1002/anie.200805396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Page JS, Tang K, Kelly RT, Smith RD. Anal Chem. 2008;80:1800. doi: 10.1021/ac702354b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kelly RT, Page JS, Luo Q, Moore RJ, Orton DJ, Tang K, Smith RD. Anal Chem. 2006;78:7796. doi: 10.1021/ac061133r. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S3. Plot of peak width vs. d (upper abscissa) and approximate post-transfer residence time (lower abscissa).

Figure S4. Mass spectrum obtained 1.2 s after that in Fig. 3D. The red arrow in the expanded window points to the monoisotopic mass position of leu enkephalin; its absence indicates that there is no observable carryover between droplets.

RESOURCES